{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Immunotherapies for Pediatric B-Cell Acute Lymphoblastic Leukemia Patients

Purpose of Activity

To provide information on the management of children with B-cell acute lymphoblastic leukemia (B-ALL) using immunotherapies.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe current therapies for pediatric B-ALL patients.
  2. Identify several therapies being investigated in ongoing clinical studies with pediatric B-ALL patients.
Price: $12.95


  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: OT0519
Published: May 2019
Expires: 3/5/2021
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Richard Simoneaux
Categories: Cancer , Oncology , Pediatrics
Specialties: Oncology, Pediatrics